Form 4: Cumberland Pharmaceuticals Executive Reports Stock Transaction
SEC Form 4 Filing
Todd M. Anthony, Vice President of Organizational Development at Cumberland Pharmaceuticals, reports a transaction involving common stock and options.
Summary
- On March 23, 2024, Todd M. Anthony, Vice President of Organizational Development at Cumberland Pharmaceuticals, reported a transaction.
- The transaction involved the disposition of 816 shares of common stock at a price of $1.81.
- Following the transaction, Mr. Anthony directly owns 16,328 shares of common stock.
- Mr. Anthony also acquired 3,000 options with an exercise price of $1.71 on March 25, 2024, exercisable from March 25, 2028, and expiring on March 25, 2034.
- Following the transaction, Mr. Anthony directly owns 15,000 options.
Sentiment
Score: 5
Explanation: This is a neutral report of an insider transaction. The sentiment is neither positive nor negative as it simply reflects required disclosures.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/23/2024 | Date of common stock transaction |
| 03/25/2024 | Date of options acquisition |
| 03/25/2028 | Options exercisable date |
| 03/25/2034 | Options expiration date |
| 03/26/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.